SATINDER PUREWAL: Open Payments
NPI 1528161908 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$160 in 7 payments from 6 companies in 2025. Trend: 2023 $305 · 2024 $411 · 2025 $160
Food & beverage: $160
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 1 | $40 |
| E.R. Squibb & Sons, L.L.C. | 2 | $31 |
| Orexo US, Inc. | 1 | $25 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| ABBVIE INC. | 1 | $19 |
Products named: SUBLOCADE, COBENFY, Zubsolv, INGREZZA, CAPLYTA, VRAYLAR.
Industry payments across AZ — which companies pay providers there.
